| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |